Study validates Matritech's bladder cancer test
This article was originally published in Clinica
Executive Summary
Matritech's NMP22 BladderChek Test can detect cancers missed by cystoscopy - the reference standard used to diagnose bladder cancer, according to a study published in the Journal of the American Medical Association (JAMA) (February 16). The American Cancer Society says that approximately 13,000 people in the US will die from bladder cancer in 2005.